#Coronavirus Disease Research #References (by AMEDEO, January 19 '25)

 

J Infect

1. NURMI V, Mayne R, Knight C, Almonacid-Mendoza HL, et al
   Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
   J Infect. 2025 Jan 9:106412. doi: 10.1016/j.jinf.2025.106412.
   PubMed         Abstract available
   
   
2. RJOOB K, Antonelli M, Murray B, Molteni E, et al
   Symptom Evolution in Individuals with Ongoing Symptomatic COVID-19 and Post COVID-19 Syndrome After SARS-CoV-2 Vaccination Versus Influenza Vaccination.
   J Infect. 2025 Jan 10:106406. doi: 10.1016/j.jinf.2024.106406.
   PubMed         Abstract available
   
   
3. WENDEL-GARCIA PD, Ceccato A, Motos A, Franch-Llasat D, et al
   Empirical antibiotic therapy improves outcomes in mechanically ventilated patients with COVID-19: An emulated targeted trial within a prospective, multicentre cohort study.
   J Infect. 2025 Jan 13:106411. doi: 10.1016/j.jinf.2025.106411.
   PubMed         Abstract available
   
   
4. ROMERO-RAMIREZ A, Somasundaran A, Kontogianni K, Parkes J, et al
   Evaluation of the diagnostic accuracy of Xpert(R) Mpox and STANDARD M10 MPX/OPX for the detection of monkeypox virus.
   J Infect. 2025 Jan 15:106413. doi: 10.1016/j.jinf.2025.106413.
   PubMed         Abstract available
   
   

   
   J Med Virol

5. BIRD PW, Zolana B, Oladejo S, Gurung S, et al
   Changing Patterns of Seasonal Respiratory Virus Incidence (2018-2023) Pre- and Post-COVID-19, Leicester, UK.
   J Med Virol. 2025;97:e70148.
   PubMed        
   
   
6. HUYGHE E, Abrams S, Andre E, Anseeuw K, et al
   Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status.
   J Med Virol. 2025;97:e70167.
   PubMed         Abstract available
   
   
7. SANCHEZ-SIMARRO A, Cuevas-Ferrando E, Fernandez-Soto D, Grau B, et al
   Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay Results.
   J Med Virol. 2025;97:e70130.
   PubMed         Abstract available
   
   
8. AREVALO-HERRERA M, Rincon-Orozco B, Gonzalez-Escobar JM, Herrera-Arevalo SM, et al
   Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.
   J Med Virol. 2025;97:e70133.
   PubMed         Abstract available
   
   
9. CHUA HK, Singh A, Wang Y, Goh YS, et al
   Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol.
   J Med Virol. 2025;97:e70174.
   PubMed         Abstract available
   
   
10. ZHOU X, Liu H, Yang S, Dong X, et al
    Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High-Throughput Antiviral Screening Using Gibson DNA Assembly.
    J Med Virol. 2025;97:e70171.
    PubMed         Abstract available
    
    
11. ALOSAIMI B, Awadalla M, Alturaiki W, Chen Z, et al
    A 10 Year Long-Lived Cellular and Humoral MERS-CoV Immunity Cross-Recognizing the Wild-Type and Variants of SARS-CoV-2: A Potential One-Way MERS-CoV Cross-Protection Toward a Pan-Coronavirus Vaccine.
    J Med Virol. 2025;97:e70071.
    PubMed         Abstract available
    
    
12. SILVERIO BS, Guilardi MD, Martins JO, Duro RLS, et al
    Coronavirus Cryptic Landscape and Draft Genome of a Novel CoV Clade Related to MERS From Bats Circulating in Northeastern Brazil.
    J Med Virol. 2025;97:e70173.
    PubMed         Abstract available
    
    

    
    J Virol

13. NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al
    Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
    J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390.
    PubMed         Abstract available
    
    
14. CAI C, Pham TNQ, Adam D, Brochiero E, et al
    Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
    J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235.
    PubMed         Abstract available
    
    

    
    Lancet

15. THORNTON J
    Every Story Matters: public voices in the COVID-19 Inquiry.
    Lancet. 2025 Jan 14:S0140-6736(25)00095-9. doi: 10.1016/S0140-6736(25)00095.
    PubMed        
    
    

    
    Lancet Infect Dis

16. ALVES K, Kotloff K, McClelland RS, Kouassi A, et al
    Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.
    Lancet Infect Dis. 2025 Jan 14:S1473-3099(24)00670.
    PubMed         Abstract available
    
    
17. YADAV PD, Patil DY
    Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose.
    Lancet Infect Dis. 2025 Jan 14:S1473-3099(25)00005.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

18. PAPA A, Barile JP, Jia H, Thompson WW, et al
    Gaps in Mental Health Care-Seeking Among Health Care Providers During the COVID-19 Pandemic - United States, September 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:19-25.
    PubMed         Abstract available
    
    

    
    Science

19. VAN KERKHOVE MD
    Don't pretend COVID-19 didn't happen.
    Science. 2025;387:229.
    PubMed         Abstract available